Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1999 1
2001 4
2003 1
2008 2
2009 1
2010 1
2015 1
2016 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

11 results

Results by year

Filters applied: . Clear all
Page 1
Stenting versus endarterectomy for treatment of carotid-artery stenosis.
Brott TG, Hobson RW 2nd, Howard G, Roubin GS, Clark WM, Brooks W, Mackey A, Hill MD, Leimgruber PP, Sheffet AJ, Howard VJ, Moore WS, Voeks JH, Hopkins LN, Cutlip DE, Cohen DJ, Popma JJ, Ferguson RD, Cohen SN, Blackshear JL, Silver FL, Mohr JP, Lal BK, Meschia JF; CREST Investigators. Brott TG, et al. N Engl J Med. 2010 Jul 1;363(1):11-23. doi: 10.1056/NEJMoa0912321. Epub 2010 May 26. N Engl J Med. 2010. PMID: 20505173 Free PMC article. Clinical Trial.
Restenosis: an overview.
Casterella PJ. Casterella PJ. Front Radiat Ther Oncol. 2001;35:147-71. doi: 10.1159/000061274. Front Radiat Ther Oncol. 2001. PMID: 11351944 Review. No abstract available.
Restenosis after Angioplasty.
Moussavian M, Casterella PJ, Teirstein PS. Moussavian M, et al. Among authors: casterella pj. Curr Treat Options Cardiovasc Med. 2001 Apr;3(2):103-113. doi: 10.1007/s11936-001-0066-x. Curr Treat Options Cardiovasc Med. 2001. PMID: 11242557
Prevention of coronary restenosis.
Casterella PJ, Teirstein PS. Casterella PJ, et al. Cardiol Rev. 1999 Jul-Aug;7(4):219-31. doi: 10.1097/00045415-199907000-00014. Cardiol Rev. 1999. PMID: 10423674 Review.
One-year results of the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) Study.
Giustino G, Baber U, Mastoris I, Vlachojannis GJ, Yu J, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Nikolsky E, Wong SC, Theodoropoulos KN, Dangas GD, Mehran R. Giustino G, et al. Among authors: casterella pj. Catheter Cardiovasc Interv. 2016 Mar;87(4):703-9. doi: 10.1002/ccd.26106. Epub 2015 Oct 20. Catheter Cardiovasc Interv. 2016. PMID: 26481591 Clinical Trial.
Safety of concomitant therapy with eptifibatide and enoxaparin in patients undergoing percutaneous coronary intervention: results of the Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study.
Bhatt DL, Lee BI, Casterella PJ, Pulsipher M, Rogers M, Cohen M, Corrigan VE, Ryan TJ Jr, Breall JA, Moses JW, Eaton GM, Sklar MA, Lincoff AM; Coronary Revascularization Using Integrilin and Single bolus Enoxaparin Study. Bhatt DL, et al. Among authors: casterella pj. J Am Coll Cardiol. 2003 Jan 1;41(1):20-5. doi: 10.1016/s0735-1097(02)02631-1. J Am Coll Cardiol. 2003. PMID: 12570939 Free article. Clinical Trial.
Ionic low-osmolar versus nonionic iso-osmolar contrast media to obviate worsening nephropathy after angioplasty in chronic renal failure patients: the ICON (Ionic versus non-ionic Contrast to Obviate worsening Nephropathy after angioplasty in chronic renal failure patients) study.
Mehran R, Nikolsky E, Kirtane AJ, Caixeta A, Wong SC, Teirstein PS, Downey WE, Batchelor WB, Casterella PJ, Kim YH, Fahy M, Dangas GD. Mehran R, et al. Among authors: casterella pj. JACC Cardiovasc Interv. 2009 May;2(5):415-21. doi: 10.1016/j.jcin.2009.03.007. JACC Cardiovasc Interv. 2009. PMID: 19463464 Free article. Clinical Trial.
11 results